Considerations for the Selection and Use of Disinfectants Against SARS-CoV-2 in a Health Care Setting-Reference-Cited by-同舟云学术

Considerations for the Selection and Use of Disinfectants Against SARS-CoV-2 in a Health Care Setting

Published:2020-08-31 Issue:9 Volume:7 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Tyan Kevin¹²^ORCID,Levin Adriane¹³,Avalos-Pacheco Alejandra¹⁴⁵,Plana Deborah¹⁶⁷,Rand Eleanor A¹⁸,Yang Helen¹⁴,Maliszewski Laura E¹⁴⁹¹⁰,Chylek Lily A¹¹⁰,Atta Lyla¹¹¹,Tye Mark A¹¹²¹³,Carmack Mary M¹⁴¹⁴,Oglesby N Synclaire¹⁹,Burgin Susan¹²¹⁵,Yu Sherry H¹¹⁶,LeBoeuf Nicole R¹³⁵,Kemp Jacqueline M¹³

Affiliation:

1. Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA

2. Harvard Medical School, Boston, Massachusetts, USA

3. Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts, USA

4. Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA

5. Dana-Farber Cancer Institute, Boston, Massachusetts, USA

6. Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts, USA

7. Harvard Ludwig Cancer Research Center and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA

8. Harvard University Department of Systems Biology, Cambridge, Massachusetts, USA

9. Harvard Program in Therapeutic Science, Cambridge, Massachusetts, USA

10. Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA

11. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

12. Harvard University Graduate School of Arts and Sciences, Cambridge, Massachusetts, USA

13. Massachusetts General Hospital Center for Systems Biology, Boston, Massachusetts, USA

14. Computational Health Informatics Program, Boston Children’s Hospital, Boston, Massachusetts, USA

15. Brigham and Women’s Hospital, Boston, Massachusetts, USA

16. Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA

Abstract

Abstract Proper disinfection using adequate disinfecting agents will be necessary for infection control strategies against coronavirus disease 2019 (COVID-19). However, limited guidance exists on effective surface disinfectants or best practices for their use against severe acute respiratory coronavirus 2. We outlined a process of fully characterizing over 350 products on the Environmental Protection Agency List N, including pH, method of delivery, indication for equipment sterilization, and purchase availability. We then developed a streamlined set of guidelines to help rapidly evaluate and select suitable disinfectants from List N, including practicality, efficacy, safety, and cost/availability. This resource guides the evaluation of ideal disinfectants amidst practical considerations posed by the COVID-19 pandemic.

Funder

Harvard MIT Center for Regulatory Sciences

National Institutes of Health

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa396/33702093/ofaa396.pdf

Reference22 articles.

1. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1;van Doremalen;N Engl J Med,2020